日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VDAC2 loss elicits tumour destruction and inflammation for cancer therapy

VDAC2缺失可引发肿瘤破坏和炎症,从而促进癌症治疗。

Sujing Yuan # ,Renqiang Sun # ,Hao Shi ,Nicole M Chapman ,Haoran Hu ,Cliff Guy ,Sherri Rankin ,Anil Kc ,Gustavo Palacios ,Xiaoxi Meng ,Xiang Sun ,Peipei Zhou ,Xiaoyang Yang ,Stephen Gottschalk ,Hongbo Chi

Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling

带有亮氨酸拉链的模块化嵌合细胞因子受体通过 JAK/STAT 信号传导增强 CAR-T 细胞的抗肿瘤活性

Matthew Bell, Shannon Lange, Besian I Sejdiu, Jorge Ibanez, Hao Shi, Xiang Sun, Xiaoxi Meng, Phuong Nguyen, Morgan Sutton, Jessica Wagner, Anil Kc, Deanna Langfitt, Sagar L Patil, Haiyan Tan, Ram Vinay Pandey, Yuxin Li, Zuo-Fei Yuan, Alejandro Allo Anido, Mitchell Ho, Heather Sheppard, Peter Vogel, 

CRISPR screens unveil nutrient-dependent lysosomal and mitochondrial nodes impacting intestinal tissue-resident memory CD8+ T cell formation

CRISPR筛选揭示了影响肠道组织驻留记忆CD8+ T细胞形成的营养依赖性溶酶体和线粒体节点。

Jana L Raynor ,Nicholas Collins ,Hao Shi ,Cliff Guy ,Jordy Saravia ,Seon Ah Lim ,Nicole M Chapman ,Peipei Zhou ,Yan Wang ,Yu Sun ,Isabel Risch ,Haoran Hu ,Anil Kc ,Renqiang Sun ,Sharad Shrestha ,Hongling Huang ,Jon P Connelly ,Shondra M Pruett-Miller ,Miguel Reina-Campos ,Ananda W Goldrath ,Yasmine Belkaid ,Hongbo Chi

Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

单细胞 CRISPR 筛选在体内绘制癌症中 T 细胞命运调控组图谱

Peipei Zhou # ,Hao Shi # ,Hongling Huang # ,Xiang Sun ,Sujing Yuan ,Nicole M Chapman ,Jon P Connelly ,Seon Ah Lim ,Jordy Saravia ,Anil Kc ,Shondra M Pruett-Miller ,Hongbo Chi

CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer's disease pathology

CXCR6 调控脑内 CD8+ T 细胞的驻留并限制小鼠阿尔茨海默病病理。

Wei Su # ,Jordy Saravia # ,Isabel Risch ,Sherri Rankin ,Cliff Guy ,Nicole M Chapman ,Hao Shi ,Yu Sun ,Anil Kc ,Wei Li ,Hongling Huang ,Seon Ah Lim ,Haoran Hu ,Yan Wang ,Danting Liu ,Yun Jiao ,Ping-Chung Chen ,Hadeer Soliman ,Koon-Kiu Yan ,Jonathan Zhang ,Peter Vogel ,Xueyan Liu ,Geidy E Serrano ,Thomas G Beach ,Jiyang Yu ,Junmin Peng ,Hongbo Chi

PTEN directs developmental and metabolic signaling for innate-like T cell fate and tissue homeostasis

PTEN 指导发育和代谢信号传导,实现先天性 T 细胞命运和组织稳态

Daniel Bastardo Blanco #, Nicole M Chapman #, Jana L Raynor #, Chengxian Xu, Wei Su, Anil Kc, Wei Li, Seon Ah Lim, Stefan Schattgen, Hao Shi, Isabel Risch, Yu Sun, Yogesh Dhungana, Yunjung Kim, Jun Wei, Sherri Rankin, Geoffrey Neale, Paul G Thomas, Kai Yang, Hongbo Chi

CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity

CRISPR筛选揭示了T细胞免疫营养许可的信号枢纽

Lingyun Long # ,Jun Wei # ,Seon Ah Lim ,Jana L Raynor ,Hao Shi ,Jon P Connelly ,Hong Wang ,Cliff Guy ,Boer Xie ,Nicole M Chapman ,Guotong Fu ,Yanyan Wang ,Hongling Huang ,Wei Su ,Jordy Saravia ,Isabel Risch ,Yong-Dong Wang ,Yuxin Li ,Mingming Niu ,Yogesh Dhungana ,Anil Kc ,Peipei Zhou ,Peter Vogel ,Jiyang Yu ,Shondra M Pruett-Miller ,Junmin Peng ,Hongbo Chi

Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine

磷脂酰乙醇胺对TFH细胞和体液免疫的代谢调控

Guotong Fu ,Clifford S Guy ,Nicole M Chapman ,Gustavo Palacios ,Jun Wei ,Peipei Zhou ,Lingyun Long ,Yong-Dong Wang ,Chenxi Qian ,Yogesh Dhungana ,Hongling Huang ,Anil Kc ,Hao Shi ,Sherri Rankin ,Scott A Brown ,Amanda Johnson ,Randall Wakefield ,Camenzind G Robinson ,Xueyan Liu ,Anthony Sheyn ,Jiyang Yu ,Suzanne Jackowski ,Hongbo Chi

Protein Prenylation Drives Discrete Signaling Programs for the Differentiation and Maintenance of Effector Treg Cells

蛋白质异戊二烯化驱动效应 Treg 细胞分化和维持的离散信号通路

Wei Su ,Nicole M Chapman ,Jun Wei ,Hu Zeng ,Yogesh Dhungana ,Hao Shi ,Jordy Saravia ,Peipei Zhou ,Lingyun Long ,Sherri Rankin ,Anil Kc ,Peter Vogel ,Hongbo Chi

Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy

靶向REGNASE-1可诱导长寿命效应T细胞用于癌症治疗

Jun Wei ,Lingyun Long ,Wenting Zheng ,Yogesh Dhungana ,Seon Ah Lim ,Cliff Guy ,Yanyan Wang ,Yong-Dong Wang ,Chenxi Qian ,Beisi Xu ,Anil Kc ,Jordy Saravia ,Hongling Huang ,Jiyang Yu ,John G Doench ,Terrence L Geiger ,Hongbo Chi